Welcome to our dedicated page for Oaktree Acquisition III Life Sciences news (Ticker: OACC), a resource for investors and traders seeking the latest updates and insights on Oaktree Acquisition III Life Sciences stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Oaktree Acquisition III Life Sciences's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Oaktree Acquisition III Life Sciences's position in the market.
Oaktree Acquisition Corp. III Life Sciences announced that starting December 16, 2024, holders of units from its initial public offering can separately trade Class A ordinary shares and warrants. Units will continue trading on Nasdaq as 'OACCU', while separated Class A shares and warrants will trade under 'OACC' and 'OACCW' respectively.
To separate units, holders must contact Continental Stock Transfer & Trust Company. Only whole warrants will trade, with no fractional warrants issued. The initial offering was underwritten by Jefferies , Citigroup Global Markets Inc., and UBS Investment Bank as joint book-running managers. The SEC declared the registration statement effective on October 23, 2024.
FAQ
What is the current stock price of Oaktree Acquisition III Life Sciences (OACC)?
What is the market cap of Oaktree Acquisition III Life Sciences (OACC)?
